Cost-Effectiveness of Maternal RSVpreF Vaccination Compared with Newborn Nirsevimab RSV Prophylaxis or No RSV Prophylaxis in Switzerland
Jamie Bainbridge, Stuart Mealing, Charlotte Graham, Mathias Jenal, Nicolas von Dombrowski, Amy Dymond
Springer Nature ·
2026-08-12
· DOI 10.1007/s40258-026-01063-1
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Jamie Bainbridge, Stuart Mealing, Charlotte Graham, Mathias Jenal, Nicolas von Dombrowski, Amy Dymond. Cost-Effectiveness of Maternal RSVpreF Vaccination Compared with Newborn Nirsevimab RSV Prophylaxis or No RSV Prophylaxis in Switzerland. // Applied Health Economics and Health Policy. – 2026. – DOI: 10.1007/s40258-026-01063-1. – URL: https://doi.org/10.1007/s40258-026-01063-1
Jamie Bainbridge, Stuart Mealing, Charlotte Graham, Mathias Jenal, Nicolas von Dombrowski, & Amy Dymond (2026). Cost-Effectiveness of Maternal RSVpreF Vaccination Compared with Newborn Nirsevimab RSV Prophylaxis or No RSV Prophylaxis in Switzerland. Applied Health Economics and Health Policy. https://doi.org/10.1007/s40258-026-01063-1
Jamie Bainbridge, et al. “Cost-Effectiveness of Maternal RSVpreF Vaccination Compared with Newborn Nirsevimab RSV Prophylaxis or No RSV Prophylaxis in Switzerland.” Applied Health Economics and Health Policy, 2026. doi:10.1007/s40258-026-01063-1.
@article{Bainbridge2026,
title = {Cost-Effectiveness of Maternal RSVpreF Vaccination Compared with Newborn Nirsevimab RSV Prophylaxis or No RSV Prophylaxis in Switzerland},
author = {Bainbridge, Jamie and Mealing, Stuart and Graham, Charlotte and Jenal, Mathias and Dombrowski, Nicolas von and Dymond, Amy},
journal = {Applied Health Economics and Health Policy},
year = {2026},
doi = {10.1007/s40258-026-01063-1},
url = {https://doi.org/10.1007/s40258-026-01063-1}
}